DATE: 2012-05-18

New York Times		Wall Street Journal		Forbes		Economic Times, Indiatimes
A Stem-Cell-Based Drug Gets Approval in Canada By Andrew Pollack		Personalized Rx for Children Pfizer's Xalkori, Used in Adults With Lung Cancer, Appears Effective Against Rare Childhood Tumors By Ron Winslow		Brain Twister: Study Showing Good Cholesterol Isn't So Good Could Still Be Good For Good Cholesterol-Boosting Drugs By Matthew Herper		Dr Reddy's Laboratories launches Clopidogrel tablets in US market By IST, PTI

DATE: 2012-05-17

Economic Times, Indiatimes		Bloomberg Businessweek		BBC		Boston Globe
How Piramal Healthcare is trying to build an entire business around discovering new drugs By Deepali Gupta		Glaxo’s Melanoma Cocktail Slows Cancer in Study By Makiko Kitamura, Robert Langreth		NHS 'should consider giving statins to healthy people' By James Gallagher		Study questions effect of ‘good’ cholesterol on cardiac health By Carolyn Y. Johnson, Deborah Kotz

DATE: 2012-05-16

BBC		Wall Street Journal		Wall Street Journal, Health Blog		Forbes
US sets 2025 goal to tame Alzheimer's By Correspondent		New Bid to Prevent Alzheimer's Early By Shirley S. Wang, Louise Radnofsky		Cost Of Cancer Pills Can Be Hard For Medicare Patients To Swallow By Michelle Andrews		Drug Companies Are Testing Health Technology By Zina Moukheiber

DATE: 2012-05-15

Wall Street Journal, Health Blog		Forbes		Economic Times, Indiatimes		BBC
New Caution Urged Over Sole Oral MS Drug On the Market By WSJ Staff		Revised Recommendations for Vaccines Are Being Phased In, CDC Report Says By Gergana Koleva		Government plans a crackdown on pharma firms selling drugs as dietary supplements By Khomba Singh		Large city hospitals 'breed and spread' MRSA By Michelle Roberts

DATE: 2012-05-14

The Telegraph		Economic Times, Indiatimes		Wall Street Journal, Health Blog		Boston Globe, Innovation Economy
Nice 'to reverse ban on prostate cancer drug' By Correspondent		Shantha Biotech hopes for revival as it aims to relaunch Shan5 By Khomba Singh		Reader Consult: To Approve or Not to Approve? By WSJ Staff		A new twist on the home office By Scott Kirsner

DATE: 2012-05-11

NPR		Forbes		Economic Times, Indiatimes		Business Standard
FDA Panel Recommends First HIV-Prevention Drug By Associated Press		Arena Pharmaceuticals Wins Big. What's Next? By Matthew Herper		Ranbaxy boosts presence in Africa with malaria drug By IST, IANS		India drugs inquiry can prompt new US scrutiny A parliamentary panel said drug regulator had been colluding with pharma companies to speed up approval process By Reuters

DATE: 2012-05-10

New York Times		Economic Times, Indiatimes		Boston Globe		BBC
Arthritis Pill From Pfizer Wins Support Of U.S. Panel By Katie Thomas		Cipla breached patent rights by slashing cancer drug price: Bayer Pharma By IST, PTI		Proposed new diagnosis for bipolar disorder divides psychiatrists By Patricia Wen		Stem cell shield 'could protect cancer patients' By James Gallagher

DATE: 2012-05-09

Bloomberg		Boston Globe		Economic Times, Indiatimes		BBC
Glaxo to Begin Hostile Offer for Human Genome Sciences By Makiko Kitamura, Andrea Gerlin		New data on cystic fibrosis drug lifts Vertex stock By Robert Weisman		India's main drug regulator CDSCO not properly scrutinising drugs before approving them: Parliamentary report By Reuters		'One in six cancers worldwide are caused by infection' By Michelle Roberts

DATE: 2012-05-08

BBC		Forbes		NPR, Shots Blog		Economic Times, Indiatimes
US drug company to pay $1.6bn over Depakote mis-selling By Correspondent		Pfizer Rheumatoid Arthritis Pill Looks 'Approvable' By Ed Silverman		Even A Small Slowdown In Obesity's Rise Would Save Big Money By Judith Graham		Cipla considers price cuts on more cancer drugs By Reuters

DATE: 2012-05-07

Wall Street Journal		The Telegraph		Washington Post		Forbes
FDA Panel Considers HIV Drug For New Use By Jennifer Corbett Dooren		Cheap drug that combats major cause of blindness 'just as effective as more expensive treatment' By John-Paul Ford Rojas		Collaboration seeks to find new uses for failed drugs By David Brown		Here Is How We Know Gardasil Has Not Killed 100 People By Matthew Herper

DATE: 2012-05-03

BBC		NPR, Shots Blog		Businessweek		Wall Street Journal, Health Blog
Aspirin is as 'good as warfarin' for most heart failure patients By James Gallagher		A Step Forward For Gene Therapy To Treat HIV By Richard Knox		Novartis to Buy Fougera for $1.5 Billion for Skin Drugs By Alex Wayne, Robert Langreth		Studies Shine Light on How Vioxx Raises Heart Risks By Jonathan D. Rockoff

DATE: 2012-05-02

Forbes		Boston Globe		New York Times		Economic Times, Indiatimes
Intel's Eric Dishman: "No One Is Building Apps For Seniors" By Zina Moukheiber		Finding alternatives to potent sedatives By Kay Lazar		Pfizer Races to Reinvent Itself By Katie Thomas		Pharma MNCs GSK, Merck, Pfizer and others prefer tie-ups over acquisitions with Indian firms By Deepika Amirapu

ABOUT BETSY RAYMOND STEVENSON

Founder and Principal, RaymondStevenson Healthcare Communications (RSHC) >>>

ABOUT RSHC
Building Healthy Relationships

Expert and creative communications services for the pharmaceutical and biotechnology industries. >>>

• Strategic media relations
• Thought leader relations
• Integrated social media relations
• Media interview coaching
• Tactical support
• Issues management
• Global expertise
• Developing world expertise

PROFESSIONAL SOURCES